Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Gag- and Gag Peptide-Specific CD4(+) T-Cell Clones from an HIV-1-Seronegative Donor following In Vitro Immunization

od Venturini, Sara, Mosier, Donald E., Burton, Dennis R., Poignard, Pascal
Izdano 2002

Broadly neutralizing antibodies suggest new prospects to counter highly antigenically diverse viruses

od Burton, Dennis R., Poignard, Pascal, Stanfield, Robyn L., Wilson, Ian A.
Izdano 2012

Fine Mapping of the Interaction of Neutralizing and Nonneutralizing Monoclonal Antibodies with the CD4 Binding Site of Human Immunodeficiency Virus Type 1 gp120

od Pantophlet, Ralph, Ollmann Saphire, Erica, Poignard, Pascal, Parren, Paul W. H. I., Wilson, Ian A., Burton, Dennis R.
Izdano 2003

Neutralization Synergy of Human Immunodeficiency Virus Type 1 Primary Isolates by Cocktails of Broadly Neutralizing Antibodies

od Zwick, Michael B., Wang, Meng, Poignard, Pascal, Stiegler, Gabriela, Katinger, Hermann, Burton, Dennis R., Parren, Paul W. H. I.
Izdano 2001

Protection against High-Dose Highly Pathogenic Mucosal SIV Challenge at Very Low Serum Neutralizing Titers of the Antibody-Like Molecule CD4-IgG2

od Poignard, Pascal, Moldt, Brian, Maloveste, Karla, Campos, Noëlie, Olson, William C., Rakasz, Eva, Watkins, David I., Burton, Dennis R.
Izdano 2012

Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodies

od Krumm, Stefanie A., Mohammed, Hajer, Le, Khoa M., Crispin, Max, Wrin, Terri, Poignard, Pascal, Burton, Dennis R., Doores, Katie J.
Izdano u Retrovirology (2016)

Human Antibody Responses to Mature and Immature Forms of Viral Envelope in Respiratory Syncytial Virus Infection: Significance for Subunit Vaccines

od Sakurai, Hiroshi, Williamson, R. Anthony, Crowe, James E., Beeler, Judy A., Poignard, Pascal, Bastidas, Raiza B., Chanock, Robert M., Burton, Dennis R.
Izdano 1999

Heterogeneity of Envelope Molecules Expressed on Primary Human Immunodeficiency Virus Type 1 Particles as Probed by the Binding of Neutralizing and Nonneutralizing Antibodies

od Poignard, Pascal, Moulard, Maxime, Golez, Edwin, Vivona, Veronique, Franti, Michael, Venturini, Sara, Wang, Meng, Parren, Paul W. H. I., Burton, Dennis R.
Izdano 2003

Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1

od Pejchal, Robert, Walker, Laura M., Stanfield, Robyn L., Phogat, Sanjay K., Koff, Wayne C., Poignard, Pascal, Burton, Dennis R., Wilson, Ian A.
Izdano 2010

Toward a more accurate view of human B-cell repertoire by next-generation sequencing, unbiased repertoire capture and single-molecule barcoding

od He, Linling, Sok, Devin, Azadnia, Parisa, Hsueh, Jessica, Landais, Elise, Simek, Melissa, Koff, Wayne C., Poignard, Pascal, Burton, Dennis R., Zhu, Jiang
Izdano u Sci Rep (2014)

Highly Potent RANTES Analogues either Prevent CCR5-Using Human Immunodeficiency Virus Type 1 Infection In Vivo or Rapidly Select for CXCR4-Using Variants

od Mosier, Donald E., Picchio, Gastón R., Gulizia, Richard J., Sabbe, Rebecca, Poignard, Pascal, Picard, Laurent, Offord, Robin E., Thompson, Darren A., Wilken, Jill
Izdano 1999

A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals

od Walker, Laura M., Simek, Melissa D., Priddy, Frances, Gach, Johannes S., Wagner, Denise, Zwick, Michael B., Phogat, Sanjay K., Poignard, Pascal, Burton, Dennis R.
Izdano 2010

A Panel of IgG1 b12 Variants with Selectively Diminished or Enhanced Affinity for Fcγ Receptors To Define the Role of Effector Functions in Protection against HIV

od Moldt, Brian, Schultz, Niccole, Dunlop, D. Cameron, Alpert, Michael D., Harvey, Jackson D., Evans, David T., Poignard, Pascal, Hessell, Ann J., Burton, Dennis R.
Izdano 2011

Profiling Human Antibody Responses by Integrated Single-Cell Analysis

od Ogunniyi, Adebola O., Thomas, Brittany A., Politano, Timothy J., Varadarajan, Navin, Landais, Elise, Poignard, Pascal, Walker, Bruce D., Kwon, Douglas S., Love, J. Christopher
Izdano 2014

Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers

od Hessell, Ann J., Rakasz, Eva G., Poignard, Pascal, Hangartner, Lars, Landucci, Gary, Forthal, Donald N., Koff, Wayne C., Watkins, David I., Burton, Dennis R.
Izdano 2009

IDEPI: Rapid Prediction of HIV-1 Antibody Epitopes and Other Phenotypic Features from Sequence Data Using a Flexible Machine Learning Platform

od Hepler, N. Lance, Scheffler, Konrad, Weaver, Steven, Murrell, Ben, Richman, Douglas D., Burton, Dennis R., Poignard, Pascal, Smith, Davey M., Kosakovsky Pond, Sergei L.
Izdano 2014

Intrasubtype B HIV-1 Superinfection Correlates with Delayed Neutralizing Antibody Response

od Wagner, Gabriel A., Landais, Elise, Caballero, Gemma, Phung, Pham, Kosakovsky Pond, Sergei L., Poignard, Pascal, Richman, Douglas D., Little, Susan J., Smith, Davey M.
Izdano u J Virol (2017)

Two Classes of Broadly Neutralizing Antibodies within a Single Lineage Directed to the High-Mannose Patch of HIV Envelope

od Doores, Katie J., Kong, Leopold, Krumm, Stefanie A., Le, Khoa M., Sok, Devin, Laserson, Uri, Garces, Fernando, Poignard, Pascal, Wilson, Ian A., Burton, Dennis R.
Izdano u J Virol (2014)

Correction for Doores et al., Two Classes of Broadly Neutralizing Antibodies within a Single Lineage Directed to the High-Mannose Patch of HIV Envelope

od Doores, Katie J., Kong, Leopold, Krumm, Stefanie A., Le, Khoa M., Sok, Devin, Laserson, Uri, Garces, Fernando, Poignard, Pascal, Wilson, Ian A., Burton, Dennis R.
Izdano u J Virol (2015)

Identification of common features in prototype broadly neutralizing antibodies to HIV envelope V2 apex to facilitate vaccine design

od Andrabi, Raiees, Voss, James E, Liang, Chi-Hui, Briney, Bryan, McCoy, Laura E, Wu, Chung-Yi, Wong, Chi-Huey, Poignard, Pascal, Burton, Dennis R.
Izdano u Immunity (2015)